234
Participants
Start Date
July 31, 2007
Primary Completion Date
January 31, 2010
Study Completion Date
January 31, 2010
ranibizumab
Novartis Investigational Site, Melbourne
Novartis Investigative Site, Laken
Novartis Investigative Site, Leuven
Novartis Investigative Site, Liège
Novartis Investigative Site, Berlin
Novartis Investigative Site, Bonn
Novartis Investigative Site, Bremen
Novartis Investigative Site, Chemnitz
Novartis Investigative Site, Cologne
Novartis Investigative Site, Düsseldorf
Novartis Investigative Site, Kiel
Novartis Investigative Site, Leipzig
Novartis Investigative Site, Marburg
Novartis Investigative Site, München
Novartis Investigative Site, Siegburg
Novartis Investigative Site, Tübingen
Novartis Investigative Site, Würzburg
Novartis Investigative Site, Budapest
Novartis Investigative Site, Debrecen
Novartis Investigative Site, Petah Tikva
Novartis Investigative Site, Tel Aviv
Novartis Investigative Site, Tel Litwinsky
Novartis Investigative Site, Amsterdam
Novartis Investigative Site, Nijmegen
Novartis Investigative Site, Coimbra
Novartis Investigative Site, Porto
Novartis Investigative Site, Alicante
Novartis Investigative Site, Barcelona
Novartis Investigative Site, Madrid
Novartis Investigative Site, Santiago de Compostela
Novartis Investigative Site, Valencia
Novartis Investigative SIte, Ankara
Novartis Investigative Site, Bristol
Novartis Investigative Site, Southampton
Novartis Investigative Site, West Midlands
Novartis Investigative Site, Wolverhampton
Lead Sponsor
Novartis
INDUSTRY